This work was supported by grants from the National Natural Science Foundation of China(No.30400111);the Natural Science Foundation of Jiangsu Province(No.BK2004041).
The approval of using monoclonal antibodies as a targeted therapy in the management of patients with B cell lymphoma has led to new treatment options for this group of patients. Production ofmonoclonal antibodies by t...